Previous Question
48. A drug manufacturer submits a New Drug Application (NDA) to a regulatory agency. What medicinal epidemiological evidence is critically required to support this application?
Next Question
50. In clinical practice, a physician considers a patient's individual characteristics (age, comorbidities) when interpreting the results of a population-level epidemiological study. This is an example of applying which concept?
